Sigma Planning Corp’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Sigma Planning Corp’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,603	Closed	-$245K	–	1425
2021 Q4	$245K	Sell	5,603 -463	-8%	-$21.9K	0.01%	1179
2021 Q3	$308K	Buy	6,066 +433	+8%	+$22.6K	0.01%	1050
2021 Q2	$293K	Sell	5,633 -344	-6%	-$16.1K	0.01%	1100
2021 Q1	$273K	Buy	5,977 +325	+6%	+$15.9K	0.01%	1045
2020 Q4	$260K	Buy	5,652 +72	+1%	+$3.11K	0.01%	973
2020 Q3	$217K	Buy	+5,580	New	+$215K	0.01%	924

Other funds holding IDNA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Sigma Planning Corp's IDNA Position: Q1 2022 in Review

Sigma Planning Corp sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2022, closing a stake of 5,603 shares — an estimated $245K sold.

Sigma Planning Corp first reported a position in IDNA in Q3 2020 and held it in 6 quarters. The position peaked at $308K in Q3 2021. 86 funds tracked by Wall St. Rank hold IDNA as of Q1 2022.

Sigma Planning Corp reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2022 after selling out during the quarter.
Sigma Planning Corp sold 5,603 iShares Genomics Immunology and Healthcare ETF shares in Q1 2022, an estimated $245K.
Sigma Planning Corp first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 6 quarters.
Sigma Planning Corp's iShares Genomics Immunology and Healthcare ETF position peaked at $308K in Q3 2021.
86 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2022.

Based on Sigma Planning Corp's 13F filing for Q1 2022, filed 20 Apr 2022.